APRICUS BIOSCIENCES, INC. Purchase Agreements
28 Contracts & Agreements
- Form of Securities Purchase Agreement, dated January 26, 2024 (Filed With SEC on January 30, 2024)
- Form of Securities Purchase Agreement, dated September 21, 2023 (Filed With SEC on September 25, 2023)
- Form of Amendment No. 1 to Securities Purchase Agreement, by and between Seelos Therapeutics, Inc. and each purchaser identified on the signature pages thereto, dated May 19, 2023 (Filed With SEC on May 19, 2023)
- Form of Securities Purchase Agreement, dated March 10, 2023 (Filed With SEC on March 14, 2023)
- Amendment No. 5 to Asset Purchase Agreement, dated April 8, 2022, by and between Seelos Corporation and Phoenixus AG (Filed With SEC on April 11, 2022)
- Securities Purchase Agreement, dated as of November 23, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (Filed With SEC on November 24, 2021)
- Amendment No. 4 to Asset Purchase Agreement, dated February 15, 2021, by and between Seelos Corporation and Phoenixus AG (Filed With SEC on February 18, 2021)
- Securities Purchase Agreement, dated as of December 11, 2020, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC (Filed With SEC on December 17, 2020)
- Securities Purchase Agreement, dated September 4, 2020 (Filed With SEC on September 9, 2020)
- Amendment No. 2 to Asset Purchase Agreement, dated as of December 31, 2018, by and between Seelos Therapeutics, Inc. and Phoenixus AG f/k/a Vyera Pharmaceuticals AG and Turing... (Filed With SEC on November 7, 2019)
- Amendment No. 3 to Asset Purchase Agreement, dated October 15, 2019, by and between Seelos Therapeutics, Inc. and Phoenixus AG (Filed With SEC on October 21, 2019)
- Form of Securities Purchase Agreement, dated August 23, 2019 (Filed With SEC on August 27, 2019)
- Asset Purchase Agreement, dated February 15, 2019, by and between Seelos Therapeutics, Inc. and Bioblast Pharma Ltd (Filed With SEC on February 19, 2019)
- Securities Purchase Agreement, dated as of October 16, 2018, by and among Apricus Biosciences, Inc., Seelos and certain investors named therein (Filed With SEC on October 17, 2018)
- Securities Purchase Agreement dated as of September 20, 2018, between Apricus Biosciences, Inc. and the purchaser named in the signature pages thereto (Filed With SEC on September 21, 2018)
- Amendment to Asset Purchase Agreement, dated as of May 18, 2018, by and between Seelos Therapeutics, Inc. and Vyera Pharmaceuticals AG f/k/a Turing Pharmaceuticals AG (Filed With SEC on August 31, 2018)
- Asset Purchase Agreement, dated as of March 6, 2018, by and between Seelos Therapeutics, Inc. and Vyera Pharmaceuticals AG f/k/a Turing Pharmaceuticals AG (Filed With SEC on August 31, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on March 29, 2018)
- Securities Purchase Agreement dated as of September 10, 2017, between Apricus Biosciences, Inc. and each purchaser named in the signature pages thereto (Filed With SEC on September 11, 2017)
- ASSET PURCHASE AGREEMENT By and between FERRING INTERNATIONAL CENTER S.A. And APRICUS BIOSCIENCES, INC., NEXMED (U.S.A.), INC., NEXMED HOLDINGS, INC., AND NEXMED INTERNATIONAL... (Filed With SEC on March 8, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 28, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on September 26, 2016)
- REAL ESTATE PURCHASE AGREEMENT (Filed With SEC on March 18, 2013)
- PURCHASE AGREEMENT (Filed With SEC on July 3, 2008)
- PURCHASE AGREEMENT (Filed With SEC on October 31, 2007)
- COMMON STOCK PURCHASE WARRANT Warrant To Purchase 2,663,400 Shares of Common Stock of NEXMED, INC. (Filed With SEC on December 21, 2006)
- SECURITIES PURCHASE AGREEMENT by and between NEXMED, INC., NEXMED (U.S.A.), INC. and METRONOME LPC 1, INC., dated as of November 30, 2006 SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 4, 2006)
- COMMON STOCK PURCHASE WARRANT Warrant To Purchase _________ Shares of Common Stock of NEXMED, INC. (Filed With SEC on January 27, 2006)
